Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Frederic Colombel

Showing results (451-460 of 463) with videos related to

Pageof 47
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 17, 2020
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative ColitisParambir S Dulai, Siddharth Singh, Niels Vande Casteele, et al.
Gastroenterology|April 1, 2020
Deep Remission at 1 Year Prevents Progression of Early Crohn's DiseaseRyan C Ungaro, Clara Yzet, Peter Bossuyt, et al.
Gastroenterology|September 27, 2020
Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related DiseaseMayte Suárez-Fariñas, Minami Tokuyama, Gabrielle Wei, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitisPablo Canales-Herrerias, Mathieu Uzzan, Akihiro Seki, et al.
Science Immunology|April 19, 2024
Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitisPablo Canales-Herrerias, Mathieu Uzzan, Akihiro Seki, et al.
The American Journal of Gastroenterology|October 3, 2022
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS ConsortiumAmanda M Johnson, Maria Barsky, Waseem Ahmed, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2020
Gastrointestinal involvement attenuates COVID-19 severity and mortalityAlexandra E Livanos, Divya Jha, Francesca Cossarini, et al.
Gastroenterology|May 30, 2025
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel DiseaseJurij Hanžel, Virginia Solitano, Sudheer Kumar Vuyyuru, et al.
Gastroenterology|July 5, 2022
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease, Christopher Ma, Jurij Hanzel, et al.
Gastroenterology|March 7, 2021
Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal SymptomsAlexandra E Livanos, Divya Jha, Francesca Cossarini, et al.
Pageof 47

Showing results (451-460 of 463) with videos related to

Sort By:
Pageof 47
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 17, 2020
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative ColitisParambir S Dulai, Siddharth Singh, Niels Vande Casteele, et al.
Gastroenterology|April 1, 2020
Deep Remission at 1 Year Prevents Progression of Early Crohn's DiseaseRyan C Ungaro, Clara Yzet, Peter Bossuyt, et al.
Gastroenterology|September 27, 2020
Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related DiseaseMayte Suárez-Fariñas, Minami Tokuyama, Gabrielle Wei, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitisPablo Canales-Herrerias, Mathieu Uzzan, Akihiro Seki, et al.
Science Immunology|April 19, 2024
Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitisPablo Canales-Herrerias, Mathieu Uzzan, Akihiro Seki, et al.
The American Journal of Gastroenterology|October 3, 2022
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS ConsortiumAmanda M Johnson, Maria Barsky, Waseem Ahmed, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2020
Gastrointestinal involvement attenuates COVID-19 severity and mortalityAlexandra E Livanos, Divya Jha, Francesca Cossarini, et al.
Gastroenterology|May 30, 2025
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel DiseaseJurij Hanžel, Virginia Solitano, Sudheer Kumar Vuyyuru, et al.
Gastroenterology|July 5, 2022
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease, Christopher Ma, Jurij Hanzel, et al.
Gastroenterology|March 7, 2021
Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal SymptomsAlexandra E Livanos, Divya Jha, Francesca Cossarini, et al.
Pageof 47